A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

NCT05568706 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

RSV Infection

Interventions

DRUG: EDP-938
DRUG: Placebo

Sponsor

Enanta Pharmaceuticals, Inc